Structures by: Bakthadoss M.
Total: 126
Compound 13a
C23H19N3O4
Organic letters (2009) 11, 19 4466-4469
a=11.8479(8)Å b=11.2380(6)Å c=14.6655(10)Å
α=90.00° β=98.437(2)° γ=90.00°
Compound 4a
C24H22N2O6
Organic letters (2009) 11, 19 4466-4469
a=9.9987(5)Å b=10.4124(4)Å c=11.1163(5)Å
α=102.951(2)° β=104.668(2)° γ=104.178(2)°
C20H19NO3,C20H17NO3
C20H19NO3,C20H17NO3
RSC Advances (2020) 10, 52 31570-31574
a=14.1749(9)Å b=16.1144(8)Å c=14.9624(11)Å
α=90.00° β=91.976(6)° γ=90.00°
C25H22N2O3
C25H22N2O3
RSC Advances (2020) 10, 32 19003-19007
a=11.2883(4)Å b=9.8313(4)Å c=18.7276(7)Å
α=90° β=101.498(4)° γ=90°
C25H18N2O3
C25H18N2O3
RSC Advances (2020) 10, 32 19003-19007
a=9.6663(14)Å b=10.7447(16)Å c=10.7533(10)Å
α=66.900(12)° β=85.830(10)° γ=80.391(12)°
C16H18ClNO6
C16H18ClNO6
Organic & biomolecular chemistry (2020) 18, 47 9653-9659
a=11.0420(5)Å b=8.8933(5)Å c=16.9598(12)Å
α=90° β=95.377(5)° γ=90°
C25H21BrN2O8
C25H21BrN2O8
Organic & biomolecular chemistry (2019) 17, 16 3884-3893
a=8.5538(5)Å b=28.5184(14)Å c=9.9217(5)Å
α=90.00° β=104.085(5)° γ=90.00°
C22H17BrN2O6
C22H17BrN2O6
Organic & biomolecular chemistry (2019) 17, 16 3884-3893
a=8.0079(7)Å b=10.6912(11)Å c=12.9965(11)Å
α=79.773(8)° β=82.666(7)° γ=69.817(8)°
0.57(C23H17N3O)
0.57(C23H17N3O)
Organic & biomolecular chemistry (2019) 17, 19 4767-4773
a=20.4023(13)Å b=16.0765(13)Å c=11.2547(7)Å
α=90° β=90° γ=90°
C26H22N2O3
C26H22N2O3
Organic & biomolecular chemistry (2015) 13, 10 2870-2874
a=8.9280(4)Å b=10.0923(4)Å c=11.9044(5)Å
α=95.0270(10)° β=93.1720(10)° γ=98.991(2)°
C28H24N2O3
C28H24N2O3
Organic & biomolecular chemistry (2015) 13, 10 2870-2874
a=11.0752(3)Å b=10.8473(2)Å c=18.1152(4)Å
α=90.00° β=103.625(2)° γ=90.00°
C32H36N2O4S
C32H36N2O4S
Organic & biomolecular chemistry (2015) 13, 10 2870-2874
a=10.3767(4)Å b=10.8064(4)Å c=15.0426(5)Å
α=75.845(2)° β=76.824(2)° γ=62.065(2)°
C25H22N2O5S
C25H22N2O5S
Organic & biomolecular chemistry (2015) 13, 39 10007-10014
a=9.1205(7)Å b=22.1481(18)Å c=11.2162(10)Å
α=90° β=100.140(8)° γ=90°
3-(2-chlorophenyl)-5-tosyl-3,3a,4,5-tetrahydroisoxazolo [4,3-c] quinoline - 3a- carbonitrile
C24H18ClN3O3S
Organic & biomolecular chemistry (2015) 13, 39 10007-10014
a=9.398(2)Å b=9.776(2)Å c=24.059(6)Å
α=90.00° β=90.00° γ=90.00°
Coumarinopyran pyrimidinedione
C22H18N2O5
Organic & biomolecular chemistry (2015) 13, 20 5597-5601
a=15.2039(8)Å b=12.3888(6)Å c=9.8162(5)Å
α=90.00° β=98.113(2)° γ=90.00°
C34H26BrNO7S
C34H26BrNO7S
RSC Advances (2014) 4, 23 11723
a=28.633(3)Å b=9.3215(7)Å c=24.590(2)Å
α=90.00° β=115.976(3)° γ=90.00°
C34H26N2O6S
C34H26N2O6S
RSC Advances (2014) 4, 23 11723
a=8.5775(4)Å b=24.9943(13)Å c=13.7319(7)Å
α=90.00° β=103.558(2)° γ=90.00°
C46H42N6O4S
C46H42N6O4S
RSC Advances (2014) 4, 23 11723
a=10.997(5)Å b=11.276(5)Å c=14.078(5)Å
α=108.664(5)° β=95.444(5)° γ=103.641(5)°
C40H32N4O3S
C40H32N4O3S
RSC Advances (2014) 4, 23 11723
a=9.6865(2)Å b=9.0575(3)Å c=38.5100(10)Å
α=90.00° β=92.175(2)° γ=90.00°
Benzoxazole Derivatives
2(C19H18BrNO4)
RSC Advances (2018) 8, 22 12152
a=12.8540(7)Å b=9.8269(6)Å c=14.2696(11)Å
α=90.00° β=94.215(5)° γ=90.00°
1,3-benzoxazine
C18H17NO4
RSC Advances (2018) 8, 22 12152
a=7.5340(5)Å b=13.2552(10)Å c=15.2014(12)Å
α=90.00° β=90.00° γ=90.00°
Heptacyclic Benzo[a]phenazinone
C36H27BrN2O4
RSC Advances (2019) 9, 42 24314
a=10.8736(11)Å b=11.2191(11)Å c=12.8583(13)Å
α=70.525(9)° β=84.720(8)° γ=84.754(8)°
C31H19N2O6
C31H19N2O6
RSC Advances (2019) 9, 42 24314
a=12.2139(7)Å b=10.5529(9)Å c=19.644(2)Å
α=90.00° β=96.522(7)° γ=90.00°
C28H23N3O2
C28H23N3O2
Chem.Commun. (2013) 49, 10947
a=11.136(9)Å b=6.875(6)Å c=15.243(12)Å
α=90.00° β=104.490(19)° γ=90.00°
C29H26N2O5
C29H26N2O5
Chem.Commun. (2013) 49, 10947
a=12.7564(7)Å b=11.6471(7)Å c=16.8758(7)Å
α=90.00° β=106.642(3)° γ=90.00°
C23H22N2O3
C23H22N2O3
RSC Adv. (2015)
a=6.7971(8)Å b=11.2067(12)Å c=13.1499(15)Å
α=83.851(7)° β=81.150(7)° γ=76.110(7)°
Methyl 1-methyl-3,5-diphenyl-7-tosyl-3,6,7,11b-tetrahydropyrazolo[4',3':5,6]pyrano[3,4-<i>c</i>]quinoline-5a(5<i>H</i>)-carboxylate
C35H31N3O5S
Acta Crystallographica Section E (2014) 70, 12 o1295-o1296
a=10.781(5)Å b=11.682(5)Å c=14.560(5)Å
α=112.708(5)° β=91.908(5)° γ=113.180(5)°
(<i>Z</i>)-3-(4-Methoxybenzylidene)-2,3-dihydrobenzo[<i>b</i>][1,4]thiazepin-4(5<i>H</i>)-one
C17H15NO2S
Acta Crystallographica Section E (2015) 71, 1 o21-o22
a=21.434(5)Å b=5.715(4)Å c=23.870(5)Å
α=90.000° β=101.091(4)° γ=90.000°
Methyl 7-oxo-14-phenyl-1<i>H</i>,7<i>H</i>,14<i>H</i>-pyrano[3,2-<i>c</i>:5,4-<i>c</i>']dichromene-14a(6b<i>H</i>)-carboxylate]
C27H20O6
Acta Crystallographica Section E (2015) 71, 8 926-930
a=9.3980(15)Å b=14.0050(12)Å c=15.9890(13)Å
α=90.00° β=92.048(5)° γ=90.00°
Methyl 1-oxo-6-phenyl-2,3,4,12b-tetrahydro-1<i>H</i>,6<i>H</i>-chromeno[3,4-<i>c</i>]chromene-6a(7<i>H</i>)-carboxylate]
C24H22O5
Acta Crystallographica Section E (2015) 71, 8 926-930
a=11.1694(10)Å b=20.1405(19)Å c=8.5835(7)Å
α=90.00° β=96.453(3)° γ=90.00°
6-(4-Ethylphenyl)-2,4-dimethyl-1,3-dioxo-2,3,4,12b-tetrahydro-1<i>H</i>,6<i>H</i>-chromeno[4',3':4,5]pyrano[2,3-<i>d</i>]pyrimidine-6a(7<i>H</i>)-carbonitrile]
C25H23N3O4
Acta Crystallographica Section E (2015) 71, 8 926-930
a=11.4471(5)Å b=11.2076(4)Å c=16.5407(7)Å
α=90.00° β=91.990(2)° γ=90.00°
3-(2-Methylbenzylidene)-2,3-dihydro-1,5-benzothiazepin-4(5<i>H</i>)-one
C17H15NOS
Acta Crystallographica Section E (2011) 67, 2 o243
a=19.1192(5)Å b=13.0049(3)Å c=14.8903(4)Å
α=90.00° β=128.5910(10)° γ=90.00°
Methyl 3-(4-fluorophenyl)-1-methyl-1,2,3,3a,4,9b- hexahydrochromeno[4,3-<i>b</i>]pyrrole-3a-carboxylate
C20H20FNO3
Acta Crystallographica Section E (2011) 67, 2 o349
a=10.4519(4)Å b=20.6778(8)Å c=7.8508(3)Å
α=90.00° β=91.535(2)° γ=90.00°
3'-Hydroxymethyl-1'-methyl-3'-nitro-4'-(<i>o</i>-tolyl)spiro[indoline-3,2'- pyrrolidin]-2-one
C20H21N3O4
Acta Crystallographica Section E (2010) 66, 11 o2935
a=10.8757(18)Å b=13.625(2)Å c=13.656(2)Å
α=66.116(8)° β=83.715(8)° γ=78.991(9)°
1-Methyl-3-(naphthalen-1-yl)-3,3a,4,9b-tetrahydro-1<i>H</i>- chromeno[4,3-<i>c</i>]isoxazole-3a-carbonitrile
C22H18N2O2
Acta Crystallographica Section E (2011) 67, 4 o942
a=10.622(6)Å b=12.969(7)Å c=12.423(7)Å
α=90.00° β=93.64(3)° γ=90.00°
3-(3-Chlorophenyl)-1-methyl-3,3a,4,9b-tetrahydro-1<i>H</i>- chromeno[4,3-<i>c</i>]isoxazole-3a-carbonitrile
C18H15ClN2O2
Acta Crystallographica Section E (2011) 67, 4 o799
a=10.0141(4)Å b=9.2358(3)Å c=17.5945(6)Å
α=90.00° β=102.354(2)° γ=90.00°
1-Methyl-3-(2-methylphenyl)-3,3a,4,9b-tetrahydro-1<i>H</i>- chromeno[4,3-<i>c</i>][1,2]oxazole-3a-carbonitrile
C19H18N2O2
Acta Crystallographica Section E (2011) 67, 4 o905
a=11.0120(4)Å b=13.0368(4)Å c=11.1977(3)Å
α=90.00° β=97.836(2)° γ=90.00°
(<i>E</i>)-2-({2-[(<i>E</i>)-(Hydroxyimino)methyl]phenoxy}methyl)- 3-<i>o</i>-tolylacrylonitrile
C18H16N2O2
Acta Crystallographica Section E (2012) 68, 2 o484
a=7.0214(2)Å b=10.5094(3)Å c=10.8854(3)Å
α=97.6360(10)° β=95.9530(10)° γ=99.6420(10)°
(<i>Z</i>)-3-(3,4-Dimethoxybenzylidene)-2,3-dihydro-1,5-benzothiazepin-4(5<i>H</i>)-one
C18H17NO3S
Acta Crystallographica Section E (2013) 69, 4 o562-o563
a=7.0249(4)Å b=10.7949(7)Å c=10.8826(7)Å
α=91.783(3)° β=97.562(2)° γ=108.512(2)°
(<i>Z</i>)-3-(2,4-Dichlorobenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H11Cl2NOS
Acta Crystallographica Section E (2013) 69, 4 o564
a=7.879(5)Å b=9.667(5)Å c=9.979(5)Å
α=89.052(5)° β=78.161(4)° γ=83.647(5)°
Methyl (<i>E</i>)-3-(2-formylphenoxy)acrylate
C11H10O4
Acta Crystallographica Section E (2014) 70, 6 o709
a=17.7458(8)Å b=4.0629(2)Å c=14.5745(7)Å
α=90.00° β=107.868(3)° γ=90.00°
1-Methyl-3-<i>p</i>-tolyl-3,3a,4,9b-tetrahydro-1<i>H</i>-chromeno[4,3-<i>c</i>] isoxazole-3a-carbonitrile
C19H18N2O2
Acta Crystallographica Section E (2011) 67, 7 o1695
a=8.5344(3)Å b=7.6980(3)Å c=24.6017(8)Å
α=90.00° β=98.234(2)° γ=90.00°
Phenylacrylate
C18H15BrO4
Acta Crystallographica Section E (2011) 67, 12 o3322
a=8.2798(2)Å b=22.1975(5)Å c=9.2537(2)Å
α=90.00° β=99.857(2)° γ=90.00°
(2<i>Z</i>)-2-{[<i>N</i>-(2-Formylphenyl)-4-methylbenzenesulfonamido]methyl}- 3-(4-methylphenyl)prop-2-enenitrile
C25H22N2O3S
Acta Crystallographica Section E (2012) 68, 4 o1084
a=8.9432(5)Å b=10.3004(6)Å c=24.9240(15)Å
α=90.00° β=90.00° γ=90.00°
Methyl (<i>E</i>)-2-({2-[(<i>E</i>)-(hydroxyimino)methyl]phenoxy}methyl)- 3-(4-methylphenyl)acrylate
C19H19NO4
Acta Crystallographica Section E (2012) 68, 6 o1617
a=8.8683(2)Å b=9.3246(2)Å c=11.9259(3)Å
α=75.200(2)° β=76.453(2)° γ=65.1420(10)°
1-Methyl-3-(2-methylphenyl)-3a-nitro-1,2,3,3a,4,9b- hexahydrochromeno[4,3-<i>b</i>]pyrrole
C19H20N2O3
Acta Crystallographica Section E (2012) 68, 6 o1735
a=17.8782(13)Å b=8.0447(6)Å c=23.4660(17)Å
α=90.00° β=97.605(2)° γ=90.00°
Methyl (<i>E</i>)-2-[(2-nitrophenoxy)methyl]-3-phenylacrylate
C17H15NO5
Acta Crystallographica Section E (2012) 68, 6 o1748
a=24.0511(10)Å b=7.8521(3)Å c=19.7403(9)Å
α=90.00° β=121.661(3)° γ=90.00°
(<i>E</i>)-6-Methyl-3-(2-methylbenzylidene)chroman-2-one
C18H16O2
Acta Crystallographica Section E (2012) 68, 3 o791
a=9.1331(2)Å b=17.8838(5)Å c=9.6443(3)Å
α=90.00° β=118.0560(10)° γ=90.00°
Methyl (<i>Z</i>)-2-{[<i>N</i>-(2-formylphenyl)-4- methylbenzenesulfonamido]methyl}-3-phenylprop-2-enoate
C25H23NO5S
Acta Crystallographica Section E (2011) 67, 12 o3511
a=9.7475(5)Å b=21.7053(12)Å c=11.2643(6)Å
α=90.00° β=109.987(2)° γ=90.00°
1',6-Dimethyl-4'-phenyldispiro[1-benzopyran-3(4<i>H</i>),3'- pyrrolidine-2',3''-indoline]-2,2''-dione
C27H24N2O3
Acta Crystallographica Section E (2011) 67, 12 o3516-o3517
a=11.1019(5)Å b=11.1740(4)Å c=17.8156(7)Å
α=90.00° β=100.986(2)° γ=90.00°
Methyl 6-methoxy-11-(4-methoxyphenyl)-16-methyl-14-phenyl-8,12-dioxa-14,15-diazatetracyclo[8.7.0.0^2,7^.0^13,17^]heptadeca-2(7),3,5,13(17),15-pentaene-10-carboxylate
C30H28N2O6
Acta Crystallographica Section E (2014) 70, 9 127-129
a=12.9549(5)Å b=14.5280(5)Å c=13.8522(4)Å
α=90.00° β=100.433(2)° γ=90.00°
2-(1,3-Benzothiazol-2-yl)-6-ethoxyphenol
C15H13NO2S
Acta Crystallographica Section E (2011) 67, 9 o2259
a=9.8739(5)Å b=9.6222(4)Å c=13.3644(6)Å
α=90.00° β=95.269(2)° γ=90.00°
(<i>E</i>)-Methyl 3-(4-ethylphenyl)-2-{2-[(<i>E</i>)-(hydroxyimino)methyl] phenoxymethyl}acrylate
C20H21NO4
Acta Crystallographica Section E (2011) 67, 10 o2753
a=9.0053(2)Å b=9.3655(3)Å c=12.1793(3)Å
α=75.2990(10)° β=74.7560(10)° γ=64.8910(10)°
(<i>Z</i>)-Methyl 3-(2,4-dichlorophenyl)-2-[(2-formylphenoxy)methyl]acrylate
C18H14Cl2O4
Acta Crystallographica Section E (2011) 67, 10 o2738
a=17.8151(7)Å b=4.9870(2)Å c=18.8418(8)Å
α=90.00° β=97.834(2)° γ=90.00°
Methyl (2<i>E</i>)-2-({2-[(2<i>E</i>)-2-benzylidene-3-methoxy-3-oxopropyl]-1,3-\ dioxoindan-2-yl}methyl)-3-phenylprop-2-enoate
C31H26O6
Acta Crystallographica Section E (2012) 68, 5 o1563-o1564
a=10.5657(4)Å b=10.9275(5)Å c=11.8961(5)Å
α=71.250(2)° β=77.889(3)° γ=76.656(2)°
(<i>Z</i>)-3-(2-Chlorobenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H12ClNOS
Acta Crystallographica Section E (2012) 68, 7 o2283
a=8.4958(3)Å b=8.7197(3)Å c=10.0520(3)Å
α=101.9300(10)° β=95.179(2)° γ=90.314(2)°
(2<i>E</i>,2'<i>E</i>)-Dimethyl 2,2'-[(phenylazanediyl)bis(methylene)]bis(3-phenylacrylate)
C28H27NO4
Acta Crystallographica Section E (2012) 68, 7 o2265
a=9.9099(2)Å b=11.7327(2)Å c=12.4079(4)Å
α=101.131(2)° β=106.039(2)° γ=114.8170(10)°
5,5'-Methylenebis(2-isopropoxybenzaldehyde)
C21H24O4
Acta Crystallographica Section E (2012) 68, 7 o2199
a=26.337(9)Å b=28.349(10)Å c=4.990(2)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-Methyl 2-[(1,3-dioxoisoindolin-2-yl)methyl]-3-phenylacrylate
C19H15NO4
Acta Crystallographica Section E (2012) 68, 7 o2219
a=8.682(5)Å b=10.299(4)Å c=17.903(5)Å
α=90.00° β=90.00° γ=90.00°
(<i>Z</i>)-3-(2-Methoxybenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C17H15NO2S
Acta Crystallographica Section E (2012) 68, 7 o2126
a=8.6665(5)Å b=9.7612(4)Å c=10.1328(5)Å
α=108.181(3)° β=101.561(2)° γ=103.217(3)°
2-Formyl-6-methoxyphenyl cinnamate
C17H14O4
Acta Crystallographica Section E (2012) 68, 7 o2167
a=10.7908(7)Å b=10.4672(5)Å c=25.8714(17)Å
α=90.00° β=90.00° γ=90.00°
<i>rac-</i>Methyl 3-(2-methoxyphenyl)-1-phenyl-3,3a,4,9b-tetrahydro-1<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole-3a-carboxylate
C25H23NO5
Acta Crystallographica Section E (2012) 68, 7 o1987
a=18.3791(7)Å b=15.2466(6)Å c=7.7235(3)Å
α=90.00° β=90.514(2)° γ=90.00°
8-Bromo-3-(4-ethylphenyl)-1-phenyl-3,3a,4,9b-tetrahydro-1<i>H</i>- chromeno[4,3-<i>c</i>]isoxazole-3a-carbonitrile
C25H21BrN2O2
Acta Crystallographica Section E (2013) 69, 10 o1533
a=9.8813(3)Å b=9.9921(3)Å c=11.1587(3)Å
α=94.125(2)° β=92.196(2)° γ=101.500(2)°
Methyl (2<i>E</i>)-2-[(2,4-dioxo-1,3-thiazolidin-3-yl)methyl]-3- phenylprop-2-enoate
C14H13NO4S
Acta Crystallographica Section E (2012) 68, 2 o328-o329
a=11.9274(3)Å b=15.6064(6)Å c=7.2949(3)Å
α=90.00° β=90.00° γ=90.00°
Methyl (2<i>Z</i>)-2-{[<i>N</i>-(2-formylphenyl)- 4-methylbenzenesulfonamido]methyl}-3-(naphthalen-1-yl)prop-2-enoate
C29H25NO5S
Acta Crystallographica Section E (2012) 68, 2 o330-o331
a=8.0162(3)Å b=12.0887(5)Å c=13.8703(6)Å
α=107.788(2)° β=90.0680(10)° γ=93.446(2)°
2'-Hydroxymethyl-1'-(4-methylphenyl)-2'-nitro-1',2',5',6',7',7a'- hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one
C22H23N3O4
Acta Crystallographica Section E (2012) 68, 2 o277
a=8.9172(4)Å b=9.9953(4)Å c=11.5931(6)Å
α=81.257(3)° β=76.638(3)° γ=83.805(2)°
Methyl (2<i>Z</i>)-2-({<i>N</i>-[2-(hydroxymethyl)phenyl]-4- methylbenzenesulfonamido}methyl)-3-phenylprop-2-enoate
C25H25NO5S
Acta Crystallographica Section E (2012) 68, 2 o418-o419
a=7.9528(3)Å b=9.5396(3)Å c=15.3299(5)Å
α=88.253(2)° β=83.5710(10)° γ=76.215(2)°
14-Ethoxy-4,6-dimethyl-9-phenyl-8,12-dioxa-4,6- diazatetracyclo[8.8.0.0^2,7^.0^13,18^]octadeca-2(7),13,15,17-tetraene- 3,5,11-trione
C23H20N2O6
Acta Crystallographica Section E (2013) 69, 1 o80
a=16.8362(9)Å b=8.1692(4)Å c=14.4400(8)Å
α=90.00° β=98.000(3)° γ=90.00°
Methyl 4'-(4-fluorophenyl)-1'-methyl-3'-nitromethyl-2-oxospiro[indoline-3,2'-pyrrolidine]-3'-carboxylate
C21H20FN3O5
Acta Crystallographica Section E (2013) 69, 2 o278
a=8.0265(5)Å b=25.7011(15)Å c=9.7763(6)Å
α=90.00° β=90.00° γ=90.00°
Methyl 6-(4-chlorophenyl)-2,4-dimethyl-1,3-dioxo-1,2,3,4,6,6a,7,12b- octahydrochromeno[4',3':4,5]pyrano[2,3-<i>d</i>]pyrimidine-6a-carboxylate
C24H21ClN2O6
Acta Crystallographica Section E (2011) 67, 8 o1990
a=10.6177(5)Å b=11.9973(5)Å c=17.5532(8)Å
α=90.00° β=99.751(2)° γ=90.00°
(<i>E</i>)-2-(2-Formylphenoxymethyl)-3-phenylprop-2-enenitrile
C17H13NO2
Acta Crystallographica Section E (2011) 67, 8 o2000
a=8.0157(4)Å b=9.2589(4)Å c=10.2348(5)Å
α=68.283(2)° β=73.432(2)° γ=79.804(2)°
Methyl 3-(4-isopropylphenyl)-1-phenyl-3,3a,4,9b-tetrahydro- 1<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole-3a-carboxylate
C27H27NO4
Acta Crystallographica Section E (2011) 67, 8 o1989
a=9.3555(3)Å b=10.7247(4)Å c=12.0449(4)Å
α=94.7070(10)° β=104.7300(10)° γ=96.3850(10)°
(<i>E</i>)-Methyl 3-(4-chlorophenyl)-2-{2-[(<i>E</i>)-(hydroxyimino)methyl] phenoxymethyl}acrylate
C18H16ClNO4
Acta Crystallographica Section E (2011) 67, 10 o2754
a=8.8860(4)Å b=9.3428(5)Å c=12.1494(6)Å
α=72.289(3)° β=74.319(2)° γ=63.429(2)°
(<i>Z</i>)-Methyl 2-[(4-bromo-2-formylphenoxy)methyl]-3-<i>o</i>-tolylacrylate
C19H17BrO4
Acta Crystallographica Section E (2011) 67, 10 o2690
a=8.0114(2)Å b=8.6138(2)Å c=13.4827(4)Å
α=96.4660(10)° β=97.1850(10)° γ=106.546(2)°
(<i>Z</i>)-Methyl 2-bromomethyl-3-(2-chlorophenyl)acrylate
C11H10BrClO2
Acta Crystallographica Section E (2011) 67, 10 o2812
a=10.0657(7)Å b=10.2174(7)Å c=11.3598(7)Å
α=90.00° β=97.649(2)° γ=90.00°
Methyl <i>rac</i>-(2<i>R</i>,11<i>S</i>,12<i>R</i>)-12-(2-chlorophenyl)- 22-oxo-9,13,21-trioxapentacyclo[12.8.0.0^2,11^.0^3,8^.0^15,20^]docosa- 1(14),3,5,7,15(20),16,18-heptaene-11-carboxylate
C27H19ClO6
Acta Crystallographica Section E (2011) 67, 10 o2673
a=8.4441(3)Å b=9.7556(3)Å c=13.8546(5)Å
α=73.831(2)° β=82.858(2)° γ=87.962(2)°
3-[(<i>Z</i>)-Benzylidene]-2,3-dihydro-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H13NOS
Acta Crystallographica Section E (2011) 67, 11 o3061
a=10.7711(9)Å b=7.8736(7)Å c=31.610(3)Å
α=90.00° β=90.00° γ=90.00°
(<i>Z</i>)-Methyl 2-[(2-ethoxy-6-formylphenoxy)methyl]-3-(4-ethylphenyl)acrylate
C22H24O5
Acta Crystallographica Section E (2011) 67, 12 o3245
a=9.6746(3)Å b=9.9435(3)Å c=10.7935(3)Å
α=77.5950(10)° β=85.433(2)° γ=76.7520(10)°
2-[(6-Nitro-1,3-benzodioxol-5-yl)methylidene]malononitrile
C11H5N3O4
Acta Crystallographica Section E (2011) 67, 12 o3469
a=7.0953(2)Å b=8.8847(3)Å c=9.2212(3)Å
α=84.470(2)° β=67.634(2)° γ=78.874(2)°
1'-Methyl-4'-(4-methylphenyl)dispiro[1-benzopyran-3(4<i>H</i>),3'- pyrrolidine-2',3''-indoline]-2,2''-dione
C27H24N2O3
Acta Crystallographica Section E (2012) 68, 1 o11
a=10.4543(3)Å b=14.6018(4)Å c=14.7266(4)Å
α=90.00° β=104.043(2)° γ=90.00°
(<i>Z</i>)-3-(4-Chlorophenyl)-2-{[<i>N</i>-(2-formylphenyl)-4- methylbenzenesulfonamido]methyl}prop-2-enenitrile
C24H19ClN2O3S
Acta Crystallographica Section E (2012) 68, 1 o56-o57
a=8.9795(5)Å b=10.1590(5)Å c=25.1050(13)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-2-[(2-Formylphenoxy)methyl]-3-(4-methylphenyl)prop-2-enenitrile
C18H15NO2
Acta Crystallographica Section E (2012) 68, 1 o28
a=7.0792(4)Å b=13.7006(7)Å c=15.3587(9)Å
α=90.00° β=96.782(2)° γ=90.00°
(<i>E</i>)-Methyl 2-[(2-formyl-6-methoxyphenoxy)methyl]-3-phenylacrylate
C19H18O5
Acta Crystallographica Section E (2012) 68, 1 o229
a=8.4696(5)Å b=12.1662(7)Å c=16.9860(9)Å
α=94.423(3)° β=100.038(3)° γ=103.475(3)°
(2<i>S</i>,5<i>S</i>,6<i>R</i>)-5-(4-Methylphenyl)-3-phenyl-4,8-dioxa-3- azatricyclo[7.4.0.0^2,6^]trideca-1(13),9,11-triene-6-carbonitrile
C24H20N2O2
Acta Crystallographica Section E (2012) 68, 2 o283-o284
a=8.9890(16)Å b=9.8432(19)Å c=22.084(4)Å
α=90.00° β=90.00° γ=90.00°
Methyl (<i>Z</i>)-2-[(4-bromo-2-formylphenoxy)methyl]- 3-(4-methylphenyl)acrylate
C19H17BrO4
Acta Crystallographica Section E (2012) 68, 3 o775
a=7.9262(4)Å b=8.9078(5)Å c=13.2331(6)Å
α=74.387(3)° β=83.593(2)° γ=75.770(3)°
(<i>E</i>)-3-(2-Chlorophenyl)-2-[(2-formylphenoxy)methyl]prop-2-enenitrile
C17H12ClNO2
Acta Crystallographica Section E (2012) 68, 4 o934
a=7.5022(4)Å b=7.8301(4)Å c=13.2379(8)Å
α=75.470(3)° β=84.696(2)° γ=70.935(2)°
(<i>E</i>)-Methyl 3-(3,4-dimethoxyphenyl)-2-[(1,3-dioxoisoindolin-2-yl)methyl]acrylate
C21H19NO6
Acta Crystallographica Section E (2012) 68, 4 o1107
a=15.0613(8)Å b=7.6334(4)Å c=16.6354(8)Å
α=90.00° β=93.522(2)° γ=90.00°
2-(2<i>H</i>-1,3-Benzodioxol-5-yl)-1,3-benzothiazole
C14H9NO2S
Acta Crystallographica Section E (2012) 68, 4 o961
a=6.3356(2)Å b=16.3222(5)Å c=22.0471(7)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(2-Formylphenyl)-<i>p</i>--toluenesulfonamide
C14H13NO3S
Acta Crystallographica Section E (2012) 68, 4 o1009-o1010
a=11.5409(4)Å b=8.1345(2)Å c=14.1115(5)Å
α=90.00° β=97.294(2)° γ=90.00°
(<i>E</i>)-Methyl 2-benzyl-3-<i>o</i>-tolylacrylate
C18H18O2
Acta Crystallographica Section E (2012) 68, 5 o1273
a=7.6277(3)Å b=16.2167(7)Å c=11.7990(5)Å
α=90.00° β=92.419(2)° γ=90.00°
(<i>E</i>)-Methyl 2-({2-ethoxy-6-[(<i>E</i>)-(hydroxyimino)methyl]phenoxy}methyl)-3-phenylacrylate
C20H21NO5
Acta Crystallographica Section E (2012) 68, 5 o1373
a=7.4009(3)Å b=22.1125(10)Å c=11.3681(5)Å
α=90.00° β=103.5610(10)° γ=90.00°
<i>rac</i>-6-Ethoxy-3,3a,4,9b-tetrahydro-1,3-diphenyl-1<i>H</i>- chromeno[4,3-<i>c</i>]isoxazole-3a-carbonitrile
C25H22N2O3
Acta Crystallographica Section E (2012) 68, 6 o1660
a=15.2994(9)Å b=7.5421(5)Å c=18.7248(12)Å
α=90.00° β=107.596(4)° γ=90.00°
(<i>Z</i>)-3-(4-Chlorobenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H12ClNOS
Acta Crystallographica Section E (2012) 68, 7 o2130
a=9.0486(3)Å b=9.4105(3)Å c=33.4876(10)Å
α=90.00° β=90.00° γ=90.00°
(<i>Z</i>)-3-Benzyl-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H13NOS
Acta Crystallographica Section E (2012) 68, 8 o2329
a=9.3409(6)Å b=11.7876(7)Å c=11.8310(6)Å
α=90.00° β=94.727(3)° γ=90.00°
2-(2-Nitrophenyl)-1,3-benzothiazole
C13H8N2O2S
Acta Crystallographica Section E (2012) 68, 8 o2362
a=7.6092(2)Å b=12.7854(3)Å c=11.9938(3)Å
α=90.00° β=90.556(2)° γ=90.00°
2-[Hydroxy(2-methoxyphenyl)methyl]acrylonitrile
C11H11NO2
Acta Crystallographica Section E (2012) 68, 8 o2467
a=6.9063(4)Å b=8.7085(4)Å c=11.7294(6)Å
α=94.864(3)° β=98.013(3)° γ=106.579(2)°
(<i>E</i>)-3-(1,3-Benzodioxol-5-yl)-2-{[<i>N</i>-(2-formylphenyl)- 4-methylbenzenesulfonamido]methyl}prop-2-enenitrile
C25H20N2O5S
Acta Crystallographica Section E (2012) 68, 11 o3164-o3165
a=8.921(5)Å b=10.235(4)Å c=25.256(3)Å
α=90.00° β=93.380(4)° γ=90.00°
Methyl (<i>E</i>)-2-cyano-3-(6-nitro-1,3-benzodioxol-5-yl)acrylate
C12H8N2O6
Acta Crystallographica Section E (2012) 68, 11 o3184
a=10.8191(9)Å b=7.3220(6)Å c=15.4133(13)Å
α=90.00° β=91.691(2)° γ=90.00°
14-Ethoxy-4,6,9-trimethyl-8,12-dioxa-4,6- diazatetracyclo[8.8.0.0^2,7^.0^13,18^]octadeca- 2(7),13,15,17-tetraene-3,5,11-trione
C19H20N2O6
Acta Crystallographica Section E (2013) 69, 2 o272
a=9.3526(3)Å b=17.9559(5)Å c=10.9158(3)Å
α=90.00° β=101.3460(10)° γ=90.00°
(6b<i>S</i>*,14<i>R</i>*,14a<i>R</i>*)-Methyl 14-(4-methylphenyl)-7-oxo-6b,6c,7,12b,14,14a-hexahydro-1<i>H</i>- pyrano[3,2-<i>c</i>:5,4-<i>c</i>']dichromene-14a-carboxylate
C28H22O6
Acta Crystallographica Section E (2013) 69, 2 o267-o268
a=9.526(5)Å b=10.711(5)Å c=21.975(5)Å
α=90.0° β=97.397(5)° γ=90.0°